ArticleCancer science2022

Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer.

Masanori Someya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.